Gowerlabs

Gowerlabs operates in optical neuroimaging, medical devices, research tools, and wearable brain-imaging technology. Its products address research and clinical investigations using functional near-infrared spectroscopy (fNIRS). The NTS is positioned around portable system design, full-head coverage, multiple source-detector separations, and three-dimensional tomographic imaging. LUMO offers a different form factor: a wearable platform whose optical and electronic components sit on the head, avoiding bulky fibre bundles. Its hexagonal sensor tiles can be combined into scalable, high-density arrays, with measurements taken within and across tiles. These characteristics provide specific points of differentiation in system architecture and usability, rather than evidence of market leadership or commercial scale. There is also no disclosed funding stage, valuation, or investor base with which to assess financial position relative to peers. On the information available, Gowerlabs’ distinctiveness rests on its dedicated fNIRS product portfolio and its combination of portable tomographic equipment with a modular wearable platform.

Gowerlabs describes two product lines with different configurations: the NTS optical imaging system, designed for portable full-head coverage and three-dimensional tomographic imaging, and LUMO, a wearable platform built from scalable sensor tiles. LUMO’s modular design and ability to measure within and across tiles suggest a development focus on adaptable, high-density imaging setups. Consequently, the evidence supports describing Gowerlabs as continuing to develop and offer specialized neuroimaging products, not as accelerating or contracting. Further assessment of its trajectory would require dated commercial milestones, adoption figures, staffing data, or disclosed financing. Its product breadth and modular technology are observable; the pace and scale of business expansion remain unclear.